Actionable news
All posts from Actionable news
Actionable news in ARIA: ARIAD Pharmaceuticals, Inc.,

Ariad Pharmaceuticals, Inc. (ARIA) Continues to Look Compelling, Says Cowen

In a research report released Friday, Cowen analyst Chris Shibutani reiterated an Outperform rating on shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) with a price target of $10, as the company reported its second-quarter results and provided investors with an update on its regulatory, commercial and clinical progress. ARIA is currently trading at $9.63, up $0.16 or 1.69%.

Shibutani wrote, “Turning to 2Q results, our thinking heading into the quarter was that all of the above matter a great deal, but that the quarterly report would primarily serve to “remind” a broader audience of these known facts. And, hopefully, that Iclusig would not...